ES2102010T3 - Composiciones farmaceuticas de bacteriocina y su utilizacion para el tratamiento de trastornos gastrointestinales. - Google Patents

Composiciones farmaceuticas de bacteriocina y su utilizacion para el tratamiento de trastornos gastrointestinales.

Info

Publication number
ES2102010T3
ES2102010T3 ES93903521T ES93903521T ES2102010T3 ES 2102010 T3 ES2102010 T3 ES 2102010T3 ES 93903521 T ES93903521 T ES 93903521T ES 93903521 T ES93903521 T ES 93903521T ES 2102010 T3 ES2102010 T3 ES 2102010T3
Authority
ES
Spain
Prior art keywords
bacteriocine
treatment
pharmaceutical compositions
gastrointestinal disorders
gastrointestinal system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93903521T
Other languages
English (en)
Inventor
Peter Blackburn
Steven J Projan
Edward B Goldberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Microbiology Inc
Original Assignee
Applied Microbiology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Microbiology Inc filed Critical Applied Microbiology Inc
Application granted granted Critical
Publication of ES2102010T3 publication Critical patent/ES2102010T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LAS COMPOSICIONES QUE COMPRENDEN BACTERIOCINAS QUE CONTIENEN LANTIONINA TALES COMO NISIN ACTUAN COMO BACTERICIDAS BAJO CONDICIONES TALES COMO ESAS ENCONTRADAS EN EL APARATO GASTROINTESTINAL. EN UN CASO PREFERENTE LAS PREPARACIONES FARMACEUTICAS QUE CONTIENEN LAS COMPOSICIONES SON USADAS PARA EL CONTROL DE LA BACTERIA RESPONSABLE DE LAS ENFERMEDADES DEL APARATO GASTROINTESTINAL.
ES93903521T 1992-01-17 1993-01-15 Composiciones farmaceuticas de bacteriocina y su utilizacion para el tratamiento de trastornos gastrointestinales. Expired - Lifetime ES2102010T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82243392A 1992-01-17 1992-01-17
US86613592A 1992-04-09 1992-04-09

Publications (1)

Publication Number Publication Date
ES2102010T3 true ES2102010T3 (es) 1997-07-16

Family

ID=27124640

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93903521T Expired - Lifetime ES2102010T3 (es) 1992-01-17 1993-01-15 Composiciones farmaceuticas de bacteriocina y su utilizacion para el tratamiento de trastornos gastrointestinales.

Country Status (21)

Country Link
EP (1) EP0623024B1 (es)
JP (1) JP3719520B2 (es)
KR (1) KR100282166B1 (es)
AT (1) ATE152353T1 (es)
AU (1) AU672384B2 (es)
BR (1) BR9305754A (es)
CA (1) CA2127987C (es)
CZ (1) CZ282676B6 (es)
DE (1) DE69310346T2 (es)
DK (1) DK0623024T3 (es)
ES (1) ES2102010T3 (es)
FI (1) FI943261L (es)
GR (1) GR3024049T3 (es)
HU (1) HU219234B (es)
IL (1) IL104364A (es)
MX (1) MX9300207A (es)
NO (1) NO314221B1 (es)
NZ (2) NZ249007A (es)
RU (1) RU2104710C1 (es)
SK (1) SK282523B6 (es)
WO (1) WO1993013793A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4307352A1 (de) * 1992-10-29 1994-05-05 Denecke Rainer Dr Med Vet Präparat zur Therapie und insbesondere Prophylaxe von Erkrankungen des Verdauungstraktes
EP0666759A1 (de) * 1992-10-29 1995-08-16 DENECKE, Rainer Präparat zur therapie und insbesondere prophylaxe von erkrankungen des verdauungstraktes
CA2169847C (en) * 1993-08-20 2006-02-14 John Edmondson Peel Method for the prevention and treatment of bovine mastitis
US5958873A (en) * 1997-06-09 1999-09-28 University Of Cincinnati Oral formulation for treatment of bacteria-induced diseases of the colon
US5985823A (en) * 1997-06-09 1999-11-16 Ambi Inc. Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
AU2002300676B2 (en) * 1997-06-09 2006-02-09 Ambi Inc. A method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
GB9803424D0 (en) * 1998-02-18 1998-04-15 Pfizer Ltd Performance enhancement
ATE343333T1 (de) * 1999-03-05 2006-11-15 Shanbrom Tech Llc Konzentrate natürlicher farbstoffe sowie antimikrobielle nährstoffe pflanzlichen ursprungs
NL1013861C2 (nl) * 1999-12-15 2001-06-18 Stichting Tech Wetenschapp Toepassing van Nisine of derivaat daarvan.
KR100375342B1 (ko) * 2000-02-08 2003-03-08 주식회사 풀 무 원 위장 질환 개선을 위한 천연 항균물질 조성물
DE10110431A1 (de) 2001-03-05 2002-09-19 Nutrinova Gmbh Bacteriocinhaltiges Sorbinsäurepräparat als Futtermittelzusatz in der Nutztieraufzucht
DE10326346A1 (de) * 2003-06-12 2004-12-30 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Verwendung von Sorbinsäure zur Vermeidung von bakteriellen Infektionen und als Leistungsförderer bei Tieren
EP2206506A1 (en) * 2008-12-18 2010-07-14 Bracco Imaging S.p.A Probiotic formulations
JP2010270015A (ja) * 2009-05-19 2010-12-02 Adeka Clean Aid Co Ltd 乳房炎予防剤
US20110053832A1 (en) * 2009-09-03 2011-03-03 Kraft Foods Global Brands Llc Natural antimicrobial composition
JP5909821B2 (ja) * 2012-02-22 2016-04-27 株式会社Adeka ナイシン含有抗菌性組成物
CN110898211A (zh) * 2019-12-02 2020-03-24 福建省闽东水产研究所 一种体外抑制大黄鱼内脏白点致病菌的抑菌组合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989012399A1 (en) * 1988-06-22 1989-12-28 Public Health Research Institute Of The City Of Ne Nisin compositions for use as enhanced, broad range bactericides
NZ232512A (en) * 1989-02-21 1993-09-27 Viskase Corp Compositions and firms containing antibacterial agents, methods of treating foodstuffs therewith

Also Published As

Publication number Publication date
ATE152353T1 (de) 1997-05-15
MX9300207A (es) 1994-07-29
NO942644D0 (no) 1994-07-14
HUT70839A (en) 1995-11-28
HU219234B (en) 2001-03-28
RU94037764A (ru) 1996-07-27
CZ166194A3 (en) 1995-02-15
JPH07508499A (ja) 1995-09-21
NZ299034A (en) 2000-08-25
AU3475093A (en) 1993-08-03
EP0623024B1 (en) 1997-05-02
AU672384B2 (en) 1996-10-03
NO314221B1 (no) 2003-02-17
EP0623024A1 (en) 1994-11-09
SK282523B6 (sk) 2002-10-08
FI943261A0 (fi) 1994-07-08
BR9305754A (pt) 1997-10-21
GR3024049T3 (en) 1997-10-31
IL104364A0 (en) 1993-05-13
FI943261A7 (fi) 1994-09-07
CA2127987A1 (en) 1993-07-22
NO942644L (no) 1994-09-07
WO1993013793A1 (en) 1993-07-22
JP3719520B2 (ja) 2005-11-24
KR100282166B1 (ko) 2001-02-15
RU2104710C1 (ru) 1998-02-20
FI943261L (fi) 1994-09-07
CA2127987C (en) 2002-08-13
IL104364A (en) 1997-09-30
DK0623024T3 (da) 1997-12-01
CZ282676B6 (cs) 1997-08-13
HU9402110D0 (en) 1994-09-28
SK83794A3 (en) 1995-06-07
DE69310346D1 (de) 1997-06-05
NZ249007A (en) 1996-11-26
DE69310346T2 (de) 1997-08-21

Similar Documents

Publication Publication Date Title
ES2102010T3 (es) Composiciones farmaceuticas de bacteriocina y su utilizacion para el tratamiento de trastornos gastrointestinales.
DE69333775D1 (de) Synthetische katalytische freie radikalfänger, verwendbar als antioxidantien zur prävention und therapie von krankheiten
FI933770A7 (fi) Farmaseuttisia koostumuksia ihotautien hoitamiseen
CO4290424A1 (es) Pirazolopiridinas, pirrolopiridinas, composiciones farmaceu- ticas que las contienen y procedimientos para su administra- cion como antagonista del factor de liberacion de cortico- tropina
ES2096312T3 (es) Derivado de quinuclidina como antagonista de la sustancia p.
MX9301929A (es) Derivados de pirimidina y procedimientos para su preparacion.
ES2124203T1 (es) Inhibidores de elastasa de neutrofilos humanos y catepsina g humana.
CY1105834T1 (el) Χρηση παρασκευασματων για την εφαρμογη, στον κατω αναπνευστικο σωληνα αντισηπτικων παραγοντων και/ή παραγοντων που προαγουν την επουλωση των πληγων
MX9703621A (es) Nuevos derivados aminoacidos con actividad mejorada para la resistencia a drogas multiples.
MX9303799A (es) Derivados de la serie de vitamina d con modificaciones en la posicon 20, procedimiento para su preparacion, productos intermedios para este procedimiento, preparados farmaceuticos que contienen estos derivados asi como su utilizacion para la prod.
ES2178048T3 (es) Uso de rifaximina como medicamento para el tratamiento de diarrea por criptosporidiosis.
ES2157005T3 (es) Uso del acido boswellico y sus derivados para la inhibicion de la actividad normal y elevada de la elastasa de leucocitos o de la plasmina.
DK505584A (da) Administrationssaet og farmaceutiske praeparater til anvendelse dertil
ATE340561T1 (de) Verwendung von antiseptika zur herstellung von arzneimitteln zur prophylaxe und behandlung von entzündungen im korperinneren des menschen
ES2173911T3 (es) Uso de glicosidos en vitamina d para el tratamiento o prevencion de la osteoporosis.
ES2066914T3 (es) Factores a1, a2, a3 y h del antibiotico ge 2270.
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
ES2175582T3 (es) Cromanos sustituidos con sulfonamida, procedimiento para su preparacion, su utilizacion como medicamento, asi como preparados farmaceuticos que los contienen.
ES2196456T3 (es) Compuestos ciclicos de cinco eslabones en el anillo condensado que llevan un grupo sulfonamida, su uso como medicamentos y composiciones farmaceuticas que los contienen.
ES2086526T3 (es) Aplicacion medicinal de m-csf.
ES2144857T3 (es) Utilizacion de derivados benzonaftalenicos para la fabricacion de medicamentos destinados para el tratamiento de las enfermedades del sistema nervioso.
FI961494L (fi) Farmaseuttisia koostumuksia ja niiden käyttö, etenkin hermoston rappeutumissairauksien hoitamiseksi
MX9305151A (es) Metodo para el tratamiento de enfermedades de la piel.
ES2055440T3 (es) Derivados del acido quinurenico, su preparacion y composiciones farmaceuticas que los contienen.
ES2161809T3 (es) Uso de factor proliferativo osteoblastico.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 623024

Country of ref document: ES